In the present study, we studied the potential regulation by rat myometrial a1-adrenergic receptors (a1-AR) of the newly identified Gha protein/phospholipase Cd1 (PLCd1) signaling pathway and compared myometrial inositol phosphates (InsP) production and activity of the uterine circular muscle in response to a1-AR activation between mid-pregnancy and term. For this, we quantified the level of rat myometrial a1-AR coupling to Gha protein by photoaffinity-labeling, the cytosolic amount of PLCd1 enzyme by immunoblotting, and the expression level of a1-AR subtypes by RT-PCR. The results showed an increased level of a1-AR/Gha protein coupling and the amount of PLCd1 at term (C147 and C65% respectively, versus mid-pregnancy). This was correlated with an up-regulation of a1d-AR subtype (C70% versus midpregnancy). Incubation of myometrial strips with phenylephrine (Phe), a global a1-agonist, increased InsP production in a dose-dependent manner at both mid-pregnancy and term, but with an enhanced potency (tenfold decrease in EC 50 value) at term. Phe also dose-dependently induced contraction of the circular muscle at both mid-pregnancy and term. However, unlike InsP response, no amelioration of potency was observed at term. Similar results were obtained with the endogenous agonist norepinephrine. Our results show, for the first time, that rat myometrial a1d-AR/Gha/PLCd1 signaling pathway is up-regulated at term. This is associated with an increased potency of a1-AR to elicit InsP production but not uterine contraction at this period. It is thus hypothesized that a1-AR, through activation of Gha/PLCd1 system, are not primarily involved in the initiation of labor but may rather regulate responses such as myometrial cell proliferation or hypertrophy. Reproduction (2008) 135 55-62 
Introduction
It is well established that catecholamines (norepinephrine, epinephrine) regulate uterine contractility. The first evidence came from Rüsse and Marshall's works, which showed that norepinephrine, through activation of a-adrenergic receptors (a-AR), enhances the effects of uterotonic agents by improving the excitability of the uterine muscle in the guinea pig (Russe & Marshall 1970) . Moreover, Legrand and Maltier have reported evidences for a noradrenergic transmission in the control of both pregnancy and parturition in rat. For instance, administration of propranolol, a b-AR antagonist, advanced pregnancy (Maltier & Cavaillé 1975) . In contrast, administration to near term rats of prazosin, a powerful a-AR antagonist, reduced myometrial excitability and delayed parturition (Legrand & Maltier 1986 ).
Norepinephrine signals through nine different G-protein-coupled ARs divided into three subfamilies, namely a1 (a1a, a1b, a1d), a2 (a2a, a2b, a2c), and b (b1, b2, b3). Using specific radioligands, we have shown that b-and a2-AR are co-localized in the longitudinal muscle, whereas a1-AR are expressed in the circular layer of rat myometrium (Legrand et al. , 1993 . Co-activation of b-and a2-AR increases myometrial cAMP production at mid-pregnancy (Mhaouty et al. 1995) , thereby resulting in a relaxation of the longitudinal uterine smooth muscle. Near term, progesterone withdrawal associated with increase in estradiol concentrations trigger desensitization of b-adrenergic signaling pathway (Cohen-Tannoudji et al. 1991 ) and a2-AR shift to inhibitors of adenylyl cyclase (Mhaouty et al. 1995) . These events probably participate in the initiation of labor.
Activation of global a1-AR triggers phospholipase C (PLC)-mediated degradation of phosphatidyl-inositol in plasma membrane preparations from late pregnant rat and human myometrium (Breuiller-Fouche et al. 1991 , Limon-Boulez et al. 1997 . Different mammalian PLC isoforms have been described including four b (PLCb 1-4), two g (g1-2), four d (d1-4), and 3. Among the different subfamilies of PLCs, PLCb members are triggered by G-protein-coupled receptors. In many smooth muscle cell types, stimulation of the Gqa/PLCb system is intimately linked to contraction through inositol phosphates (InsP 3 )-dependent liberation of Ca 2C from intracellular stores. In line with these data, we have shown that the up-regulation of rat myometrial PLCb1 and PLCb3 and Gqa protein correlates well with the increased uterine responsiveness to oxytocin and carbachol at term (Houdeau et al. 2005) . In pregnant and parturient rat myometrium, we have also shown that stimulation of a1-AR results in the activation of Gha protein pathway (Dupuis et al. 2004) . Gha protein is a bifunctional enzyme with both transglutaminase and GTPase activities (Nakaoka et al. 1994) . By virtue of its GTP binding/GTPase activity, Gha protein acts as a signaling molecule. Nevertheless, unlike the Gqa subunit, Gha protein does not interact with the members of the PLCb family but selectively activates PLCd1 enzyme (Das et al. 1993 , Feng et al. 1996 , Baek et al. 2001 . The role of the Gha/PLCd1 signaling pathway in smooth muscle cells remains to be clearly identified. PLCd1 is, however, known to be induced during the cell cycle or by stress responses (Yagisawa et al. 2006) .
Therefore, in light of all these data, the present work was undertaken to compare the level of rat myometrial a1-AR/Gha coupling, the expression pattern of a1-AR subtypes and PLCd1 enzyme, and the potency of a1-AR to induce both myometrial InsP production and uterine contraction of the circular muscle between mid-pregnancy and term.
Results
Quantification of Gha/PLCd1 signaling components in mid-pregnant and parturient rat
We recently reported that Gha protein, a new class of GTPbinding proteins, functionally interacts with the rat myometrial a1-AR (Dupuis et al. 2004) . In order to determine whether Gha protein plays an important role in the transduction of rat myometrial a1-AR, we compared by photoaffinity labeling studies a1-AR/Gha coupling between mid-pregnancy and term. Figure 1A illustrates the net incorporation of [a 32 P]GTP into Gha protein following activation of a1-AR by 100 mM Phe. Our results show that a1-AR/Gha coupling occurred on day 12 of pregnancy and significantly increased at term (2.47-and 2.1-fold increases at term versus days 12 and 15 of pregnancy respectively; P!0.05). We also quantified, by immunoblotting, the cytosolic amount of PLCd1 enzyme, the known target of a1-AR/Gha coupling. Results illustrated in Fig. 1B show that the amount of PLCd1 increases progressively from day 12 to term when it finally reaches a maximal level (C65% at term versus day 12 of pregnancy; P!0.05).
Altogether, these results indicate that the rat myometrial a1-AR/Gha/PLCd1 signaling pathway is up-regulated at the end of pregnancy.
Correlation between rat myometrial a1d-expression and a1-AR/Gha coupling It is well known that Gha protein selectively interacts with a1b-and a1d-but not with a1a-subtype (Chen et al. 1996) . We thus characterized the expression of rat myometrial a1-adrenergic subtypes using RT-PCR technique. Our results show that the three a1-subtypes are present in rat myometrium but exhibit a differential expression during the course of pregnancy ( Fig. 2A) . Indeed, a1a-and a1d-transcripts were detected from day 12 of pregnancy until term with a significant lower level of expression (K69%, P!0.05) for a1a-and a progressive increase (C70%, P!0.05) for a1d-between day 12 of pregnancy and term (Fig. 2B ). In contrast, detectable levels of a1b-mRNAs were observed only from day 15 of pregnancy, with a significant decreased expression at term (K50% versus day 15, P!0.05).
The clear-cut increase in a1d mRNA in late pregnant myometrium concomitant with the sharp decrease in its a1b counterpart at term lead us to suggest that a1d-AR might be a good candidate for the activation of Gha/PLCd1 system. Due to the lack of enough selective tools that could discriminate in functional studies between a1b-and a1d-subtypes, we examined the relationship between the amount of a1-AR/Gha protein coupling and a1b or a1d expression. The change in the expression of a1d-mRNA correlated strongly with the change in the amount of a1-AR/Gha protein coupling (r 2 Z0.905 for a1d versus 0.277 for a1b; Fig. 3A and B). As a positive control, we assessed the relationship between the myometrial amounts of a1-AR/Gha protein coupling and PLCd1. Figure 3C shows a highly significant positive correlation (r 2 Z0.840), indicating a tight link between these two events.
Altogether, these data strongly suggest the involvement of rat myometrial a1d-AR in the regulation of Gha protein/PLCd1 signaling pathway at the end of pregnancy.
Myometrial InsP response to the activation of a1-AR in mid-pregnant and term rat Myometrial strips from mid-pregnant or parturient rats were incubated with increasing concentrations of Phe, a global a1-AR agonist. As basal InsP production significantly increases at term (Houdeau et al. 2005) , Phe-induced InsP accumulation was expressed as the percentage of its corresponding basal in order to evaluate the net responses due to the specific activation of a1-AR. Results illustrated in Fig. 4A show that Phe dose-dependently enhanced InsP production at both mid-pregnancy and term. The E max was unchanged between day 15 of pregnancy and term, while the EC 50 value was significantly decreased at term (P!0.05, Table 1 ) as evidenced by the leftward shift in the dose-response curve. Pre-treatment of myometrial strips with 100 mM prazosin, an a1-AR antagonist, completely blocked InsP production in response to maximally effective Phe (1 mM) in both pregnant and term rats (Fig. 5) . This indicates that InsP response is due to the specific activation of a1-AR at both stages of pregnancy.
These results show that the up-regulation of rat myometrial a1-AR/Gha/PLCd1 signaling pathway is associated with an amelioration of PLC/InsP response at term. Uterine contraction induced by rat myometrial a1-AR at mid-pregnancy and term
Since PLC activation is generally linked to uterine contraction, we compared, for the first time, InsP production and contraction of the circular layer of smooth muscle uterus in response to a1-AR activation.
We have previously reported that a1-AR are mainly located in the uterine circular muscle . This was confirmed by our recent functional studies, which showed that Phe specifically enhances the activity of the uterine circular muscle and has no effect on the longitudinal layer . We thus studied the contractile activity of the circular muscle layer in response to increasing concentrations of Phe. All uterine strips exhibited spontaneous rhythmic contractions a few minutes after being mounted on the bath (data not shown). As illustrated in Fig. 1B , Phe elicited a dose-dependent increase in uterine activity at both mid-pregnancy and term. An analysis of the sigmoid dose-response curves revealed no changes in the potency and maximal response for Phe between mid-pregnancy and term (Fig. 4B , Table 1 ). When challenged with the endogenous agonist norepinephrine, uterine strips exhibited a dose-dependent contraction ( Fig. 4C ) with an EC 50 value at the micromolar range (2G0.4 mM) similar to that obtained for Phe. Again, no change was observed in the maximal response (not shown).
Altogether, these results show that the up-regulation of a1-AR/Gha protein/PLCd1 and the amelioration of InsP response at term are not primarily linked to contractile activity of the circular muscle.
Discussion
We report, in the present study, an up-regulation of a1-AR/Gha protein/PLCd1 signaling pathway in term rat myometrium. Indeed, both the level of a1-AR/Gha protein coupling and the amount of PLCd1 significantly increased at this period. The enhanced a1-AR/Gha interaction could be explained by the induction of Gha expression at both mRNAs and protein levels as reported previously (Dupuis et al. 2004 ). In addition, we also showed that, among the Gha-protein-coupled a1-AR, the expression of a1b-AR was down-regulated, whereas that of a1d-AR was significantly enhanced at term. Interestingly, we found a good temporal correlation between a1-AR/Gha coupling and a1d-AR expression during the course of pregnancy. The regulatory factors underlying this up-regulation need to be determined. It is, however, interesting to note that we did not find any effect of progesterone or estradiol on Gha expression (data not shown).
We also report that the up-regulation of a1-AR/Gha protein/PLCd1 signaling pathway correlates well with the increased potency of a1-AR to induce InsP production (a tenfold lower EC 50 value) at term. This is in agreement with the increased Phe-stimulated PLC activity reported in plasma membrane preparations from term rat myometrium (Limon-Boulez et al. 1997) . Surprisingly, this was not associated with an amelioration of uterine contraction in response to either Phe or the endogenous agonist norepinephrine. Parallel experiments where InsP production and contractile activity of the circular muscle were measured in response to oxytocin indicated a higher potency for this agonist to elicit both responses at term (Houdeau et al. 2005) . This increased term sensitivity to oxytocin correlated well with the up-regulation of OTR, Gqa protein, and PLCb1/PLCb3 enzymes as shown previously (Houdeau et al. 2005) . Indeed, progesterone withdrawal and the increase in estradiol concentrations at the end of pregnancy induce expression of all these signaling molecules (Houdeau et al. 2005) . As shown by our previous pharmacological studies ( Limon-Boulez et al. 1997) and confirmed by the present study, rat myometrium expresses a heterogeneous population of a1-AR. The three a1-AR subtypes (a1a, a1b, and a1d) are present during the second half of pregnancy although they exhibit different expression patterns. Previous studies attempted to assign different roles to a1-AR subtypes in the regulation of uterine contraction (Ducza et al. 2002 , Mihalyi et al. 2003 . It is, however, clear from the present study that, in physiological conditions where the three a1-AR subtypes are co-activated by their endogenous ligand norepinephrine, contraction of the circular muscle is induced at term but not as potently as does oxytocin. Indeed, the EC 50 values calculated for norepinephrine and phenylephrine are at the micromolar range compared with the 20 nM obtained for oxytocin under similar experimental conditions (Houdeau et al. 2005) . It thus appears that rat myometrial a1-AR are not efficiently linked to the classical Gqa/PLCb system and consequently to uterine contraction. In line with this finding, we have previously shown that the Gqa/PLCbcoupled a1a-AR subtype undergoes uncoupling at term (Limon-Boulez et al. 1997) . This, together with the presently reported down-regulation of a1b-AR expression and the emergence of the a1d-AR/Gha/ PLCd1 signaling pathway, strongly suggests that a1-AR preferentially signal through Gha/PLCd1 at term. In myometrium, the physiological meaning of the emergence of a1d-AR/Gha/PLCd1 signaling pathway in the late pregnant rat myometrium remains to be determined. However, it is interesting to note that the plasma membrane a1-AR/Gha interaction takes place at mid-pregnancy and progressively increases until term. One may then postulate that this signaling pathway participates to the myometrial cell hypertrophy or proliferation that occurs during this period. Indeed, Gha protein was shown to mediate a1-AR-induced hepatocyte proliferation (Wu et al. 2000) and activation of extracellular signal-regulated kinases in neonatal rat cardiomyocytes (Lee et al. 2003) . In agreement with these results, we have recently shown that Gha protein participates to the a1-AR-mediated regulation of smooth muscle cell proliferation (Dupuis et al. 2004) . Alternatively, the a1/Gha/PLCd1 system may also play a role in the preparation of uterus to labor by regulating the expression of some contraction-associated proteins. For instance, the directed overexpression of Gha protein in cardiomyocytes resulted in the up-regulation of cyclooxygenase-2, prostaglandin F2a receptors, and Gi proteins (Zhang et al. 2003) . Mice lacking tissue transglutaminase II/Gha protein do not seem to exhibit any alteration in the pregnancy or parturition processes. However, it is possible that compensatory mechanisms taking place during development mask the real importance of myometrial Gha protein. One way to answer this question in vivo is to induce the conditional deletion of transglutaminase II/Gha in pregnant myometrium by using the smooth muscle-inducible CreERT system as was recently described by Dö ring et al. (2006) .
In conclusion, the present work describes the up-regulation of different transduction components involved in the newly identified a1/Gha/PLCd1 signaling pathway in rat myometrium between mid-pregnancy and term. The increased a1-AR/Gha coupling as well as a1d-AR and PLCd1 expression correlates well with the increased potency of a1-AR to induce myometrial InsP production but not uterine contraction at term. This lead us to hypothesize that myometrial a1d-AR, through activation of Gha/PLCd1 system, are not primarily involved in the initiation of labor but may either induce the expression of contraction-associated proteins during the phase of uterine preparation to labor and/or regulate other uterine responses like myometrial cell hypertrophy or proliferation.
Materials and Methods

Animals
Sprague-Dawley rats were obtained from Janvier (Le Genest, France). The females were caged with males overnight and successful mating was determined by the presence of spermatozoa in the vaginal smear (day 1 of pregnancy).
Animals were killed by cervical dislocation at days 12, 15, 20 of pregnancy or at term during the expulsion of fetoplacental units, following the guidelines laid down by the NIH Guide. The uterine horns were quickly isolated, cut open lengthwise and the fetoplacental units removed. The myometrium was then freed of the adherent endometrium except for uterine tension studies.
RT-PCR
Using SuperScript Reverse Transcriptase kit (Gibco BRL Life Technologies), 5 mg total RNA was reverse-transcribed and the resulting cDNA was stored at K80 8C. PCR amplification was performed with 1/20 volume of each RT reaction using specific upstream and downstream primers for a1a-, a1b-, and a1d-AR subtypes and the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as described previously (Mhaouty-Kodja et al. 2001 , Dupuis et al. 2004 . For semi-quantitative analysis, PCR cycle profiles were conducted and the cycle number (25 cycles) was chosen from the linear portion of the curve. The PCR products were separated by electrophoresis on ethidium bromide containing 2% agarose gel.
Preparation of myometrial fractions
Rat myometrium was homogenized in buffer A (50 mM Tris (pH 7.3), 100 mM NaCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 0.5 mM dithiothreitol, 0.32 M sucrose) for Western blot analysis, and in buffer B (10 mM HEPES (pH 7.5), 250 mM sucrose, 5 mM EGTA) for photoaffinity labeling experiments supplemented with a cocktail of protease inhibitors (Sigma-Aldrich). After 10 min centrifugation at 4 8C, the supernatants were collected and submitted to 100 000 g centrifugation at 4 8C for 1 h to separate plasma membranes from cytosol. The pellet containing plasma membranes was resuspended in a homogenization buffer and the protein concentration of plasma membrane and cytosolic fractions was determined according to Bradford (1976) with BSA as standard. Samples were stored at K80 8C until use.
Western blot analysis
Cytosolic samples (20 mg protein) from rat myometrium were separated by 7.5% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Perkin-Elmer Life Sciences, Paris, France). The blots were blocked overnight at 4 8C in Tris-buffered saline (TBS) containing 5% non-fat-dried milk and incubated for 1 h at room temperature with monoclonal anti-PLCd1 (Upstate Biotechnology, Euromedex, Souffelweyersheim, France) diluted 1:500. Incubation with secondary anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA, USA; 1:10 000 dilution) was carried out for 45 min at room temperature. Immunoreactive bands were visualized by the chemiluminescence detection system (Amersham Pharmacia Biotech) and quantified by densitometric scanning followed by computer analysis using the NIH image 1.62 program (http://rsb.info.nih.gov/nih-image/ download.html).
Photoaffinity labeling
Photoaffinity labeling of Gha with [a- 32 P]GTP (3000 Ci/mmol, Perkin-Elmer Life Sciences) was carried out as described previously (Dupuis et al. 2004) . Briefly, plasma membrane fractions (200 mg protein) were incubated with 10 mCi [a-32 P]GTP for 10 min at 30 8C in a labeling buffer in the absence or presence of 100 mM Phe (Sigma-Aldrich). Reactions were stopped in ice and the samples were irradiated with u.v. light (254 nm) for 20 min and solubilized with Laemmli solution for 1 h at room temperature. The samples were then subjected to SDS-PAGE in 7.5% gels and transferred to the PVDF membranes. The membranes were first autoradiographed and then immunodetected with a monoclonal antiGha diluted 1:500 from NeoMarkers (Interchim, Monluçon, France). The obtained levels of labeled Gha were normalized with the corresponding amount of immunodetected protein.
Densitometric scanning followed by computer analysis using NIH image 1.62 program was used to determine the levels of labeled and immunodetected Gha protein.
Measurement of myometrial InsP accumulation
InsP production was measured as described previously (Mhaouty-Kodja et al. 2001) . Myometrial strips were incubated at 37 8C for 4 h with 7 mCi myo-[ 3 H]inositol (10-25 Ci/mmol, Perkin-Elmer Life Sciences) in 1 ml Krebs bicarbonate buffer. Increasing concentrations (0.1 nM-1 mM) of Phe were added after 10 min incubation of the myometrial strips with 10 mM LiCl (Sigma-Aldrich) in Krebs bicarbonate buffer. Assays were stopped 15 min later by freezing the strips in liquid N 2 . When used, 100 mM prazosin was added 15 min before the addition of 100 mM Phe.
Strips were homogenized in 7% trichloroacetic acid and the obtained supernatant was extracted with diethyl ether, neutralized with Tris-base, and then chromatographed over an anion-exchange resin (AG1-X8, Bio-Rad Laboratories). Total InsP eluted with 1 M ammonium formate/0.1 M formic acid (Sigma-Aldrich) were counted by liquid scintillation in a 1214 Rack-beta spectrometer (LKB, Turku, Finland) for tritium.
Uterine contraction studies
Uterine strips, 4 mm long, were prepared from pregnant rats and mounted in organ baths containing 8 ml Krebs solution as described previously (Mhaouty-Kodja et al. 2001) . We measured isometric contractions of the circular muscle using a Bioscience UF1 tension transducer (Phymep, Paris, France) under 0.7 g resting force. A 30 min equilibration period was allowed before adding cumulative doses of Phe (0.1 nM-1 mM). The concentration-response curves were recorded by computerized calculation of the integral under the tension/time curve for 3 min using Prism 4 software (Graph Pad, San Diego, CA, USA) for sigmoidal dose-response (nonlinear regression fit). Isometric changes in tissue tension and maximal effects (E max ) were expressed as a percentage above the spontaneous activity in the absence of agonists, and potency as EC 50 .
Statistical analysis
Results are expressed as meansGS.E.M. Statistical significance was assessed by Student's t-test for unpaired data. P!0.05 was considered significant.
